April 2020 FDA Recall Drug by Lupin Pharmaceuticals Inc.
D-1250-2020 - Product Mix-Up

This Class II drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on April 20, 2020 for the product Drug. The FDA reported the reason for recall as product mix-up. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1250-2020

Reason for Recall
Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.
Initiated
04-20-2020
Reported
04-29-2020
Quantity
11,808 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lupin Pharmaceuticals Inc.
Product was distributed Nationwide in the United States.
Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

Batch or Lot Expiration Information

Lot# Q000255, Exp 01/2022